3992-45-8
3992-45-8
Chemical Structure
Decanoyl-L-carnitine
Synonym(s): (-)-Decanoylcarnitine
- CAS No.: 3992-45-8
- Formula:C17H33NO4
- Molecular Weight:315.45
IUPAC Name: (R)-3-(decanoyloxy)-4-(trimethylammonio)butanoate
InChIKey: LZOSYCMHQXPBFU-OAHLLOKOSA-N
SMILES: CCCCCCCCCC(O[C@H](CC([O-])=O)C[N+](C)(C)C)=O
Biological Activity: Decanoyl-L-carnitine ((-)-Decanoylcarnitine) is an endogenous metabolite. Decanoyl-L-carnitine can be used as a serum metabolic biomarkers as indicators in the progression of intravenous leiomyomatosis[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Decanoyl-L-carnitine | 99.85% | Decanoyl-L-carnitine ((-)-Decanoylcarnitine) is an endogenous metabolite. Decanoyl-L-carnitine can be used as a serum metabolic biomarkers as indicators in the progression of intravenous leiomyomatosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Decanoyl-L-carnitine (Standard) | ≥98% | Decanoyl-L-carnitine ((-)-Decanoylcarnitine) (Standard) is the analytical standard of Decanoyl-L-carnitine (HY-135035). This product is intended for research and analytical applications. Decanoyl-L-carnitine is an endogenous metabolite. Decanoyl-L-carnitine can be used as a serum metabolic biomarkers as indicators in the progression of intravenous leiomyomatosis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Decanoyl-L-carnitine-d3 | Decanoyl-L-carnitine ((-)-Decanoylcarnitine)-d3 is deuterium labeled Decanoyl-L-carnitine (HY-135035). Decanoyl-L-carnitine is an endogenous metabolite. Decanoyl-L-carnitine can be used as a serum metabolic biomarkers as indicators in the progression of intravenous leiomyomatosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Decanoyl-L-carnitine-d19 | Decanoyl-L-carnitine-d19 ((-)-Decanoylcarnitine-d19> is the deuterium labeled Decanoyl-L-carnitine (HY-135035). Decanoyl-L-carnitine ((-)-Decanoylcarnitine) is an endogenous metabolite. Decanoyl-L-carnitine can be used as a serum metabolic biomarkers as indicators in the progression of intravenous leiomyomatosis. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
